Literature DB >> 31734837

Movento effects on learning and hippocampal brain-derived neurotrophic factor protein of adult male rats.

Iman Zangiabadi1, Mohammad Reza Afarinesh2,3, Ali Shamsara1, Seyed Hasan Eftekhar-Vaghefi4,5.   

Abstract

Spirotetramat is a toxic commercially known as Movento used to control pistachio psylla pests. In the present study, the effects of Movento on passive avoidance learning of rats and their ability to explore the novel object in the novel object recognition test were investigated. The changes in the concentration of hippocampal brain-derived neurotrophic factor (BDNF) proteins were evaluated, too. Male Wistar rats were gavaged at different dosages of the Movento (50, 100, 250, 500, 1000, 1250, and 1500 mg/kg) or saline for 7 days (administered every 2 days). We showed that Movento caused 50 and 100% mortality at the dose of 1250 and 1500 mg/kg, respectively. At the dose of 1000 mg/kg, Movento significantly decreased locomotor activity (P < 0.05). These rats also displayed a significant decrease in the number of training trials in the shuttle box and the ability to recognize a novel object compared with the control group (P < 0.01). The BDNF protein level of hippocampus also showed a significant decrease in the Movento (1000 mg/kg) compared with the control group (P < 0.01) while the number of pancellular necrosis pyramidal CA1 cells increased significantly in the Movento group (P < 0.001). We concluded that exposure to Movento can decline sensory, motor, and learning in rats.

Entities:  

Keywords:  Learning; Memory; Movento; Rat; Spirotetramat

Mesh:

Substances:

Year:  2019        PMID: 31734837     DOI: 10.1007/s11356-019-06809-0

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  26 in total

1.  Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus.

Authors:  R M Ridley; C J Timothy; C J Maclean; H F Baker
Journal:  Neuroscience       Date:  1995-07       Impact factor: 3.590

Review 2.  A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors.

Authors:  Marzia Malcangio; Volkmar Lessmann
Journal:  Trends Pharmacol Sci       Date:  2003-03       Impact factor: 14.819

3.  Domoic acid-induced neuronal damage in the rat hippocampus: changes in apoptosis related genes (bcl-2, bax, caspase-3) and microglial response.

Authors:  C Ananth; S Thameem Dheen; P Gopalakrishnakone; C Kaur
Journal:  J Neurosci Res       Date:  2001-10-15       Impact factor: 4.164

Review 4.  Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?

Authors:  Helen E Scharfman; Neil J Maclusky
Journal:  Trends Neurosci       Date:  2005-02       Impact factor: 13.837

5.  Object recognition memory and the rodent hippocampus.

Authors:  Nicola J Broadbent; Stephane Gaskin; Larry R Squire; Robert E Clark
Journal:  Learn Mem       Date:  2009-12-22       Impact factor: 2.460

6.  Ameliorative effects of vitamin C on short-term sensorimotor and cognitive changes induced by acute chlorpyrifos exposure in Wistar rats.

Authors:  Suleiman F Ambali; Sherifat B Idris; Charles Onukak; Mufta'u Shittu; Joseph O Ayo
Journal:  Toxicol Ind Health       Date:  2010-06-16       Impact factor: 2.273

Review 7.  Interactions between estradiol, BDNF and dendritic spines in promoting memory.

Authors:  V Luine; M Frankfurt
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

8.  Oral intake of hydrogen-rich water ameliorated chlorpyrifos-induced neurotoxicity in rats.

Authors:  Tingting Wang; Ling Zhao; Mengyu Liu; Fei Xie; Xuemei Ma; Pengxiang Zhao; Yunqi Liu; Jiala Li; Minglian Wang; Zhaona Yang; Yutong Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2014-06-24       Impact factor: 4.219

9.  Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions.

Authors:  Betina Elfving; Pia Høgh Plougmann; Gregers Wegener
Journal:  J Neurosci Methods       Date:  2010-01-05       Impact factor: 2.390

10.  Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.

Authors:  Susanne Bäck; Johan Peränen; Emilia Galli; Päivi Pulkkila; Liina Lonka-Nevalaita; Tuulia Tamminen; Merja H Voutilainen; Atso Raasmaja; Mart Saarma; Pekka T Männistö; Raimo K Tuominen
Journal:  Brain Behav       Date:  2013-01-14       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.